[Video Profile] Interview with Eric Le Royer, CEO of EndoSense SA

Endosense is developing a catheter ablation treatment for cardiac rhythm disorders, including atrial fibrillation (AF). AF is the most common […]

Read more »

Endologix Rejects Elliott Associates Buyout Bid

Regular Sentinel readers know I’m a fan of Endologix. The developer of a minimally invasive treatment for abdominal aortic aneurysms […]

Read more »

Endocare and Galil Medical to Merge

Only months after Healthtronics withdrew its offer to acquire Endocare for $2.28 per share, Endocare and privately held Galil Medical […]

Read more »

Abiomed: Record Revenue Driven by Impella

In June, Abiomed got the green light from the FDA to market its Impella 2.5 CAD, a minimally invasive ventricular […]

Read more »

[Video Interview] Richard Taney, President & CEO of Delcath Systems

One of the central problems in using chemotherapy to treat cancer is its harmful effect on organ health. Lower dosages […]

Read more »

Cyberkinetics Neurotechnology Nearing Paralysis

In a recent filing, Cyberkinetics Neurotechnology said it only had enough cash to last 30 days. If negotiations fail with […]

Read more »

AngioDynamics Integrates Diomed’s EVLT

Having acquired onetime rival Diomed for a song, AngioDynamics has launched a new varicose vein therapy brand, VenaCure EVLT. The […]

Read more »

Symphony Medical Raises $10 Million

Symphony Medical, a privately-held company developing novel biocompatible polymer therapies to treat chronic heart failure and atrial fibrillation has raised […]

Read more »

CryoLife: EPS Increases, Revenues Up 21%

Revenues at CryoLife rose 21% to $26.8 million in the third quarter of 2008. Net income was $3.6 million, or […]

Read more »

What’s Next for the Battered Laser Aesthetics Industry?

During times of economic malaise, discretionary income tends to decline. For many, it’s difficult to justify spending money on one’s […]

Read more »